1. TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA
2. Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
3. Department of Pathology, Brigham and Women’s Hospital, Boston, MA
4. Cardiovascular Division, Women’s College Hospital and Toronto General Hospital, University of Toronto, Toronto, Canada
5. AstraZeneca Research and Development, Wilmington, DE
6. Bristol-Myers Squibb, Princeton, NJ
7. Cardiovascular Research Institute, Lady Davis Carmel Medical Center and Ruth and Bruce Rappaport School of Medicine Technion-IIT, Haifa, Israel
8. Cardiovascular Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
9. Division of Endocrinology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
10. Département Hospitalo-Universitaire FIRE, INSERM U-1148, Université Paris-Diderot, Hôpital Bichat, AP-HP, Paris, France, NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK